BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

DEUTSCHE BANK AG\'s Holding History (CIK: 0000948046)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 860,000 Value ($000) $845 Avg Close Range
Q2 2022
Shares 750,000 Value ($000) $743 Avg Close Range
Q1 2022
Shares 1,350,000 Value ($000) $1,350 Avg Close Range
Q4 2021
Shares 1,200,000 Value ($000) $1,254 Avg Close Range
Q3 2021
Shares 1,200,000 Value ($000) $1,228 Avg Close Range
Q1 2021
Shares 3,481,000 Value ($000) $3,523 Avg Close Range
Q4 2020
Shares 6,146,000 Value ($000) $6,595 Avg Close Range
Q3 2020
Shares 7,389,000 Value ($000) $7,753 Avg Close Range
Q2 2020
Shares 2,900,000 Value ($000) $3,544 Avg Close Range
Q1 2020
Shares 5,107,000 Value ($000) $5,352 Avg Close Range
Q4 2019
Shares 5,058,000 Value ($000) $5,343 Avg Close Range
Q3 2019
Shares 3,672,000 Value ($000) $3,609 Avg Close Range
Q2 2019
Shares 3,624,000 Value ($000) $3,762 Avg Close Range
Q1 2019
Shares 5,395,000 Value ($000) $5,519 Avg Close Range
Q4 2018
Shares 3,868,000 Value ($000) $3,845 Avg Close Range
Q3 2018
Shares 8,170,000 Value ($000) $8,706 Avg Close Range
Q2 2018
Shares 9,370,000 Value ($000) $9,465 Avg Close Range
Q1 2018
Shares 6,351,000 Value ($000) $5,960 Avg Close Range
Q4 2017
Shares 7,956,000 Value ($000) $7,925 Avg Close Range
Q3 2017
Shares 3,218,000 Value ($000) $3,260 Avg Close Range